Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin
CAS NO: 1297538-32-9
Fomil molekile: C19H19ClN6O2
Molekile Pwa: 398.846
EINECS NO: 829-313-8
MDL NO: MFCD294727270
Pwodwi Deskripsyon:
Non pwodwi: Darolutamide CAS NON: 1297538-32-9
Sinonim:
ODM-201;
N-(S) -1-(3-(3-chloro-4-cyanophenyl) -1H-pyrazol-1-yl) -propan-2-yl) -5-(1-hydroxyethyl) -1H-prayzole-3-kaboxamide;
Chimik & Pwopriyete fizik:
Aparans: Likid jon likid
Assay: ≥99.0%
Dansite: 1.4 g / cm3
Bouyi pwen: 719.5 ° C nan 760 mmHg
Flash Point: 388.9 ° C
ODM-201, ke yo rele tou Darolutamide, se yon nouvo-jenerasyon, ki pisan ak resepte androgen selektif (AR) inibitor ki se potansyel itil pou tretman nan kanse pwostat castration-reziste (CRPC). ODM-201 se yon antagonist plen ak segonde-affinity AR ki, menm jan ak dezyem jenerasyon antiandrogens anzalutamide ak ARN-509, inibit testostewon-induit translokasyon nikleye nan AR. Enpotan, ODM-201 tou bloke aktivite a nan Brs yo mutant teste rive nan repons a terapi antitandrojen, ki gen ladan mitasyon an F876L ki konfere rezistans nan anzalamide ak ARN-509. Anplis de sa, ODM-201 diminye kwasans lan nan AR-overexpressing VCaP selil pwostat tou de nan vitro ak nan yon castration-reziste model VCaP xenograft. ODM-201 simonte rezistans nan AR-vize terapi pa antagonizing tou de overexpressed ak mutated ARs. ODM-201 se kounye a nan yon faz 3 jijman nan CRPC.
Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!
Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.
Baj popilè: darolutamide cas 1297538-32-9, manifaktire, founise, faktori, achte, nan stock